US approves Tykerb for advanced breast cancer
602931
US drug regulators approved Tuesday the targeted anti-cancer treatment Tykerb (lapatinib) for use together with another drug, Xeloda (capectabine) in certain advanced breast cancers.
563877
A new type of breast cancer drug is  clearly superior to the old standard, tamoxifen, in many women  and should now be the first drug used to treat the cancer, U.S.  and British researchers said on Wednesday.
64073
Tysabri, a treatment for multiple sclerosis, received regulatory approval on Monday for use among patients with Crohnâs disease.
564004
Tysabri, a treatment for multiple sclerosis made by Biogen Idec Inc. and Elan Corp., received regulatory approval on Monday for use among patients with a severe intestinal disorder.
102970
A combination drug treatment that includes Tykerb, know generically as lapatinib, appears to be able to fight breast cancer that has spread to the brain, GlaxoSmithKline Plc announced Sunday.
205305
Federal health advisers on Wednesday recommended approval of the first new cancer drug in the past decade specifically aimed at treating the most common childhood leukemia.
295140
U.S. health officials approved a genetic test on Tuesday that can give women with early breast cancer an estimate of whether the disease is likely to return in five to 10 years.
493049
U.S. health regulators on Wednesday approved Wyeth's drug Torisel for patients with an advanced form of kidney cancer called renal cell carcinoma, saying it helped them live longer.
283280
New treatment guidelines for breast cancer patients in the United States could spark changes to management of those with the disease in Australia.
157177
WASHINGTON The Food and Drug Administration has agreed to allow broader application of a breast cancer drug. The drug (letrozole) is currently used against advanced breast cancer and the FDA will now allow
615464
The Food and Drug Administration yesterday approved a genetic test that, when conducted soon after a woman learns she has breast cancer, can predict the odds of the disease returning and worsening.
432135
The Food and Drug Administration yesterday approved a cancer drug made by pharmaceutical giant Eli Lilly and Co. to treat advanced non-small cell lung cancer in patients who have undergone chemotherapy.
467984
The US Food and Drug Administration approved a new drug to treat patients with advanced lung cancer. It&#39;s called Alimta. Patients receive ten minute infusions of the drug every three weeks on an outpatient basis.
256613
(letrozole) is the first therapy approved by theU.S. Food and Drug Administration (FDA) for the extended adjuvant treatmentof postmenopausal women with early breast cancer who have received adjuvant(post-surgery) tamoxifen therapy for five years
531441
GlaxoSmithKline Plc announced further clinical trial results on Sunday underlining the ability of a drug combination including its product Tykerb to fight breast cancer that has spread to the brain.
56445
WEDNESDAY, Jan. 16 (HealthDay News) -- A new genetic test that helps assess the risk of tumor recurrence and long-term survival for patients with relatively high-risk breast cancer has been approved by the U.S. Food and Drug Administration.
31407
A new type of breast cancer drug is  superior to the old standard, tamoxifen, in older women and  should now be the first drug used to treat the cancer, U.S. and  British researchers said on Wednesday.